ATRA vs MS · rev $128.9M vs P/E 20, $344.27B cap
Atara Biotherapeutics Inc (ATRA) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
MS does not have a complete income-statement cache yet.
ATRA currently screens at market cap $87.1M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the ATRA and MS stock pages for the full models.
Not investment advice.